ZEVRA THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Zevra Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
  • Zevra Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$27.3M, a 77.7% decline year-over-year.
  • Zevra Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$86.7M, a 98.2% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$49.6M, a 16.5% decline from 2022.
  • Zevra Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$42.6M, a 651% decline from 2021.
  • Zevra Therapeutics, Inc. annual Operating Income (Loss) for 2021 was $7.73M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$86.7M -$27.3M -$11.9M -77.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$74.8M -$23.8M -$17.5M -281% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$57.3M -$20.5M -$7.66M -59.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$49.6M -$15.2M -$5.84M -62.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$43.8M -$15.4M -$8.74M -132% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$35M -$6.25M +$18.5M +74.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$53.5M -$12.8M -$11M -590% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$42.6M -$9.31M -$6.47M -228% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$36.1M -$6.63M -$4.4M -198% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$31.7M -$24.8M -$30.6M -525% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.09M -$1.86M -$8.82M -127% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $7.73M -$2.84M +$372K +11.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $7.36M -$2.22M -$1.01M -83.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $8.37M $5.83M +$3.24M +125% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $5.13M $6.96M +$10.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$5.61M -$3.21M +$1.2M +27.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$6.81M -$1.21M -$4.45M -138% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$2.36M $2.59M +$10.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$12.7M -$3.78M +$7.59M +66.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$20.3M -$4.41M +$4.86M +52.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$25.2M $3.23M +$21.2M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$46.4M -$7.79M +$6.12M +44% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$52.5M -$11.4M +$3.4M +23% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$55.9M -$9.27M -$1.12M -13.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$54.8M -$18M -$8.35M -86.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$46.4M -$13.9M -$5.68M -69.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$40.8M -$14.8M -$7.39M -100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$33.4M -$8.15M +$2.69M +24.8% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-30
Q3 2017 -$36.1M -$9.61M +$789K +7.59% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$36.8M -$8.22M +$1.05M +11.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$37.9M -$7.38M -$410K -5.88% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$37.5M -$10.8M -$3.55M -48.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$33.9M -$10.4M -$3.92M -60.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-30
Q2 2016 -$30M -$9.28M -$3.32M -55.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-30
Q1 2016 -$26.7M -$6.97M -$3.87M -125% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-30
Q4 2015 -$22.8M -$7.28M +$206K +2.75% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$23M -$6.48M -$2.14M -49.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$20.9M -$5.96M -$2.91M -95.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$18M -$3.1M -$1.52M -96.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$16.4M -$7.49M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 -$4.34M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-16
Q2 2014 -$3.05M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-16
Q1 2014 -$1.57M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.